Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 09-07-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Revolution Medicines NASDAQ Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Revolution Medicines, Inc. announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at a public offering price of USD26.00 per share, before underwriting discounts and commissions. All of the shares of common stock were offered by Revolution Medicines. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, were expected to be approximately USD156.0 million, excluding any exercise of the underwriters' option to purchase additional shares.
Latham and Watkins LLP represented Revolution Medicines in the offering.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Issuer | Law Firm | Latham & Watkins |
| Issuer Jurisdiction- | United States | Listing Jurisdiction- | United States |
| Classification: |
Initial Public Offerings NASDAQ |
Lawyer | Mark V Roeder |
